A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers

Clinical trial NCT05874167 · COMPLETED

Trial details

NCT number: NCT05874167
Sponsor: Dong Wha Pharmaceutical Co. Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2022-08-08
Primary completion: 2022-10-11
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.